Fuchs Henry J

BioMarin Pharmaceutical Inc.

President, Worldwide R&D

Avg. Two Year Performance

No Purchase Track Record

(11%) Avg. Sale Return (5%) Compound

Holdings: 196.87K shares

Last Three Months: 25-Jan-24 -- 24-Apr-24

($3.01M) Net Amount

Buy:	0	--
Sell:	($3.01M)	$85.18

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

25-Apr-22 -- 24-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions